CUE
Cue Biopharma Inc.
$0.70
-$0.00(-0.55%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$51.65M
Volume
110.67K
52W Range
$0.45 - $1.99
Target Price
$4.00
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $1.1M | $3.5M | $3.2M | $14.9M | $1.2M | $5.5M | $9.3M | ||
| Total Revenue | $1.1M | $3.5M | $3.2M | $14.9M | $1.2M | $5.5M | $9.3M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $1.1M | $3.5M | $3.2M | $14.9M | $1.2M | $5.5M | $9.3M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-39.8M | $-40.2M | $48.2M | $58.7M | $54.7M | $57.6M | $50.8M | ||
| Research & Development | $28.5M | $27.5M | $33.5M | $41.3M | $38.6M | $40.8M | $36.3M | ||
| Research Expense | $28.5M | $27.5M | $33.5M | $41.3M | $38.6M | $40.8M | $36.3M | ||
| Selling, General & Administrative | $11.3M | $12.7M | $14.7M | $17.3M | $16.2M | $16.7M | $14.6M | ||
| General & Administrative Expenses | $11.3M | $12.7M | $14.7M | $17.3M | $16.2M | $16.7M | $14.6M | ||
| Salaries & Wages | $-7.2M | $-6.5M | $10.5M | $11.5M | $9.5M | $8.2M | $6.8M | ||
| Depreciation & Amortization | $-760.0K | $-799.1K | $780.5K | $909.1K | $831.0K | $545.0K | $385.0K | ||
| Depreciation & Amortization | $-760.0K | $-799.1K | $780.5K | $909.1K | $831.0K | $545.0K | $385.0K | ||
| Amortization | -- | $-11.7K | $11.7K | -- | $31.0K | $37.0K | $37.0K | ||
| Other Operating Expenses | $-430.0K | $-294.0K | $-341.0K | $-363.0K | $277.0K | $-424.0K | $-278.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-38.7M | $-36.8M | $-45.0M | $-43.7M | $-53.8M | $-52.1M | $-41.5M | ||
| EBITDA | $-37.4M | $-35.5M | $-45.0M | $-43.7M | $-50.5M | $-49.1M | $-39.4M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $713.0K | $1.2M | $796.0K | ||
| Intinc | $376.0K | $482.8K | $463.9K | $45.9K | $928.0K | $2.7M | $1.6M | ||
| Net Non-Operating Interest Income/Expense | $376.0K | $482.8K | $463.9K | $45.9K | $-215.0K | $1.4M | $826.0K | ||
| Gain on Sale of Securities | $612 | $637 | $17.5K | $7.1K | $96.0K | -- | -- | ||
| Other Income/Expense | $-165.3K | $-637 | $-17.5K | $-7.1K | $277.0K | $157.0K | $-93.0K | ||
| Other Special Charges | $165.3K | $64.1K | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-38.2M | $-36.3M | $-45.0M | $-43.7M | $-52.3M | $-49.5M | $-39.9M | ||
| Pre-Tax Income | $-38.2M | $-36.3M | $-44.6M | $-43.7M | $-53.0M | $-50.7M | $-40.7M | ||
| INCOME TAX | |||||||||
| Tax Provision | $825.0K | $412.5K | $206.3K | $495.0K | -- | -- | -- | ||
| NET INCOME | |||||||||
| Net Income | $-39.0M | $-36.7M | $-44.8M | $-44.2M | $-53.0M | $-50.7M | $-40.7M | ||
| Net Income (Continuing Operations) | $-39.0M | $-36.7M | $-44.8M | $-44.2M | $-53.0M | $-50.7M | $-40.7M | ||
| Net Income (Discontinued Operations) | $-39.0M | $-36.7M | $-44.8M | $-44.2M | $-53.0M | $-50.7M | $-40.7M | ||
| Net Income (Common Stockholders) | $-39.0M | $-36.7M | $-44.8M | $-44.2M | $-53.0M | $-50.7M | $-40.7M | ||
| Normalized Income | -- | -- | -- | $-34.5M | -- | -- | $-40.4M | ||
| TOTALS | |||||||||
| Total Expenses | $-39.8M | $-40.2M | $48.2M | $58.7M | $54.7M | $57.6M | $50.8M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $20.1M | $22.0M | $28.7M | $31.3M | $35.6M | $45.8M | $56.3M | ||
| Average Shares Outstanding (Diluted) | $20.1M | $22.1M | $28.7M | $31.3M | $35.6M | $45.8M | $56.3M | ||
| Shares Outstanding | $20.7M | $26.6M | $30.5M | $33.0M | $43.2M | $48.6M | $61.8M | ||
| Basic EPS | -- | -- | $-1.56 | $-1.41 | $-1.49 | $-1.11 | $-0.72 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-1.56 | $-1.41 | $-1.49 | $-1.11 | $-0.72 | ||
| Diluted EPS | $-1.94 | $-1.66 | $-1.56 | $-1.41 | $-1.49 | $-1.11 | $-0.72 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-1.49 | $-1.11 | $-0.72 | ||
| OTHER METRICS | |||||||||
| Gain On Sale Of P P E | $-3.3K | -- | -- | -- | -- | $-157.0K | $93.0K | ||
| Net Income Discontinuous Operations | $58.0K | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $11.3M | $12.7M | $14.7M | $17.3M | $16.2M | $16.7M | $14.6M | ||
| Provision For Gain Loss On Disposal | $58.0K | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $11.3M | $12.7M | $4.6M | $5.0M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CUE | $0.70 | -0.6% | 110.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |